ArticleFrontiers in artificial intelligence2026
Deep learning-based assessment of coronary artery disease using curved-multiplanar reconstruction: comprehensive evaluation of stenosis, calcification, and plaque.
Article in Frontiers in artificial intelligence, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: This study developed and validated a deep learning-based framework to detect and quantify coronary artery stenosis, vulnerable plaque, and calcification in Curved-Multiplanar Reconstruction (cMPR) images to support clinical decision-making in coronary artery disease (CAD). Methods: We analyzed 1,715 patients (5,112 vessels) from 2014 to 2022. Each vessel was reconstructed into a cMPR scan consisting of 13 sequential cross-sectional slices. Using a 2D nnU-Net framework, we developed a Stenosis Segmentation Model (SSM) and a Vulnerable Plaque Segmentation Model (VPSM). A time-independent test set ( Results: The SSM achieved a vessel-level sensitivity of 0.84 and a high NPV of 0.98. The MAE for diameter stenosis was 12.4%, with a mean bias of +1.2% in Bland-Altman analysis, demonstrating robust agreement with expert references across the full test spectrum. For vulnerable plaque detection, the VPSM achieved a sensitivity of 0.80 and an NPV of 0.97 at the slice level. Calcification assessment showed high inter-rater reliability (ICC = 0.84) and substantial agreement with expert visual scoring (Kappa = 0.76). Conclusion: The proposed automated analysis demonstrated high diagnostic reliability, particularly in its negative predictive power, making it a powerful non-invasive tool for CAD screening. By providing objective quantification of stenosis, calcification, and vulnerable plaques, this method offers a significant advancement in standardized cMPR evaluation in clinical environments.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.